EDGAR Filing Documents for 0001140361-17-040291

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001140361-17-040291

Filing Date

2017-10-31

Accepted

2017-10-31 16:20:06

Documents

Period of Report

2017-10-27

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 3	doc1.html	3
1	FORM 3	doc1.xml	3	8130
	Complete submission text file	0001140361-17-040291.txt		11408

Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 450 KENDALL STREET CAMBRIDGE MA 02142

Business Address 450 KENDALL STREET CAMBRIDGE MA 02142 6174259200

MPM Oncology Impact Management LP (Reporting) CIK: 0001687078 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 171165950

Mailing Address 450 KENDALL STREET CAMBRIDGE MA 02142

Business Address 450 KENDALL STREET CAMBRIDGE MA 02142 617-425-9200

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 171165948

Mailing Address 450 KENDALL STREET CAMBRIDGE MA 02142

Business Address 450 KENDALL STREET CAMBRIDGE MA 02142 6174259200

MPM Oncology Impact Management GP LLC (Reporting) CIK: 0001721035 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 171165951

Mailing Address 450 KENDALL STREET CAMBRIDGE MA 02142

Business Address 450 KENDALL STREET CAMBRIDGE MA 02142 6174259200

Oncology Impact Fund (Cayman) Management L.P. (Reporting) CIK: 0001721036 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 171165949